MXPA01008910A - Compuestos de tiazoloindolinona. - Google Patents

Compuestos de tiazoloindolinona.

Info

Publication number
MXPA01008910A
MXPA01008910A MXPA01008910A MXPA01008910A MXPA01008910A MX PA01008910 A MXPA01008910 A MX PA01008910A MX PA01008910 A MXPA01008910 A MX PA01008910A MX PA01008910 A MXPA01008910 A MX PA01008910A MX PA01008910 A MXPA01008910 A MX PA01008910A
Authority
MX
Mexico
Prior art keywords
compound
thiazolindolinone
thiazolo
dihydro
indol
Prior art date
Application number
MXPA01008910A
Other languages
English (en)
Spanish (es)
Inventor
Ambrish Vyas
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MXPA01008910A publication Critical patent/MXPA01008910A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
MXPA01008910A 1999-03-04 2000-03-01 Compuestos de tiazoloindolinona. MXPA01008910A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904930.6A GB9904930D0 (en) 1999-03-04 1999-03-04 Thiazoloindolinone compounds
PCT/US2000/005192 WO2000052013A2 (en) 1999-03-04 2000-03-01 Thiazoloindolinone compounds

Publications (1)

Publication Number Publication Date
MXPA01008910A true MXPA01008910A (es) 2002-03-27

Family

ID=10848912

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01008910A MXPA01008910A (es) 1999-03-04 2000-03-01 Compuestos de tiazoloindolinona.

Country Status (18)

Country Link
EP (1) EP1159280A2 (xx)
JP (1) JP2003532620A (xx)
KR (1) KR20020005606A (xx)
CN (1) CN1355807A (xx)
AU (1) AU3611000A (xx)
BR (1) BR0008677A (xx)
CA (1) CA2361580A1 (xx)
CZ (1) CZ20013187A3 (xx)
GB (1) GB9904930D0 (xx)
HK (1) HK1041692A1 (xx)
HU (1) HUP0200376A3 (xx)
IL (1) IL144808A0 (xx)
MX (1) MXPA01008910A (xx)
NO (1) NO20014262L (xx)
PL (1) PL351476A1 (xx)
TR (1) TR200102557T2 (xx)
WO (1) WO2000052013A2 (xx)
ZA (1) ZA200106826B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
WO2006060614A1 (en) * 2004-12-01 2006-06-08 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Methods for preparing pimecrolimus
UA103319C2 (xx) * 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Сполуки бензенсульфонамідтіазолу та -оксазолу$соединения бензенсульфонамидтиазола и -оксазола
JP4761000B1 (ja) * 2010-11-08 2011-08-31 小野薬品工業株式会社 手足症候群の予防および／または治療剤
WO2011125763A1 (ja) 2010-03-31 2011-10-13 小野薬品工業株式会社 手足症候群の予防および／または治療剤
CN111601617A (zh) 2017-12-13 2020-08-28 上海岸阔医药科技有限公司 一种用于预防或治疗与egfr 被抑制相关疾病的方法
CN111989095A (zh) 2018-04-16 2020-11-24 上海岸阔医药科技有限公司 预防或治疗肿瘤疗法副作用的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511852A (ja) * 1997-05-07 2002-04-16 スージェン・インコーポレーテッド 蛋白質キナーゼ活性の調節剤としての２−インドリノン誘導体
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Also Published As

Publication number Publication date
GB9904930D0 (en) 1999-04-28
AU3611000A (en) 2000-09-21
IL144808A0 (en) 2002-06-30
BR0008677A (pt) 2002-01-08
WO2000052013A2 (en) 2000-09-08
PL351476A1 (en) 2003-04-22
EP1159280A2 (en) 2001-12-05
TR200102557T2 (tr) 2007-01-22
KR20020005606A (ko) 2002-01-17
NO20014262L (no) 2001-10-30
WO2000052013A3 (en) 2000-12-28
CN1355807A (zh) 2002-06-26
CA2361580A1 (en) 2000-09-08
HUP0200376A2 (en) 2002-06-29
NO20014262D0 (no) 2001-09-03
HK1041692A1 (zh) 2002-07-19
HUP0200376A3 (en) 2003-07-28
CZ20013187A3 (cs) 2002-02-13
ZA200106826B (en) 2003-02-25
JP2003532620A (ja) 2003-11-05

Similar Documents

Publication Publication Date Title
ES2199156T3 (es) Derivados de aza-oxindol sustituidos.
US6818632B2 (en) 3-(anilinomethylene)oxindoles
US6369086B1 (en) Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors
US6624171B1 (en) Substituted aza-oxindole derivatives
US7189716B2 (en) Tyrosine kinase inhibitors
CN108368089A (zh) 新化合物
US6498176B1 (en) 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
CZ139097A3 (cs) 6-Arylpyrido[2,3-d]pyrimidiny a naftyridiny a farmaceutické prostředky na jejich bázi
CZ302486B6 (cs) N-6-Substituovaný 7-deazapurin, zpusob jeho prípravy a farmaceutická kompozice s jeho obsahem
SK3542002A3 (en) Pteridinones as kinase inhibitors
PT1246623E (pt) Compostos específicos para o receptor de adenosina a1,a2a e a3 e as suas utilizações
KR20190104632A (ko) 트라이사이클릭 자이라제 억제제
CA2623507C (en) Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
JP6797923B2 (ja) Ａｌｋおよびｓｒｐｋ阻害剤ならびに使用方法
JP2022517085A (ja) ハロゲン化アリルアミン系化合物及びその適用
KR20080032104A (ko) 지에이비에이 에이 수용체 리간드의 할로겐화된피라졸오[1,5-에이]피리미딘, 이들의 제조 방법,이들의조성물 및 중간체
JP2004508366A (ja) オキシインドール誘導体
MXPA01008910A (es) Compuestos de tiazoloindolinona.
US6492398B1 (en) Thiazoloindolinone compounds
EP0550566A1 (en) Antiproliferative substituted naphthalene compounds
KR100723854B1 (ko) 4,5-아졸로-옥신돌
JP2003502362A (ja) 化学療法および／または放射線療法の副作用の苛酷さを防止／軽減するための組成物および方法
WO2021168341A1 (en) Solid forms of 1-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-n,n-dimethylmethanamine
CN112079836A (zh) 三唑并嘧啶类化合物及其盐、组合物和应用
CA2965813A1 (en) Spirocyclic containing compounds and pharmaceutical uses thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal